Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C66H75Cl2N9O24 |
Molecular Weight | 1449.254 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 18 / 18 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]2(O[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1)[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC3=C4OC5=CC=C(C=C5Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]6C(C=C3OC7=C(Cl)C=C(C=C7)[C@@H](O)[C@@H]8NC(=O)[C@H](NC6=O)C9=CC(=C(O)C=C9)C%10=C(C=C(O)C=C%10O)[C@H](NC8=O)C(O)=O)=C4
InChI
InChIKey=MYPYJXKWCTUITO-LYRMYLQWSA-N
InChI=1S/C66H75Cl2N9O24/c1-23(2)12-34(71-5)58(88)76-49-51(83)26-7-10-38(32(67)14-26)97-40-16-28-17-41(55(40)101-65-56(54(86)53(85)42(22-78)99-65)100-44-21-66(4,70)57(87)24(3)96-44)98-39-11-8-27(15-33(39)68)52(84)50-63(93)75-48(64(94)95)31-18-29(79)19-37(81)45(31)30-13-25(6-9-36(30)80)46(60(90)77-50)74-61(91)47(28)73-59(89)35(20-43(69)82)72-62(49)92/h6-11,13-19,23-24,34-35,42,44,46-54,56-57,65,71,78-81,83-87H,12,20-22,70H2,1-5H3,(H2,69,82)(H,72,92)(H,73,89)(H,74,91)(H,75,93)(H,76,88)(H,77,90)(H,94,95)/t24-,34+,35-,42+,44-,46+,47+,48-,49+,50-,51+,52+,53+,54-,56+,57+,65-,66-/m0/s1
Molecular Formula | C66H75Cl2N9O24 |
Molecular Weight | 1449.254 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 18 / 18 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:07:18 UTC 2023
by
admin
on
Sat Dec 16 17:07:18 UTC 2023
|
Record UNII |
6Q205EH1VU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
NBK548881
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.2.2
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
||
|
NCI_THESAURUS |
C61101
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
||
|
NDF-RT |
N0000007889
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
||
|
WHO-VATC |
QA07AA09
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
867521
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
||
|
FDA ORPHAN DRUG |
361211
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
||
|
WHO-ATC |
J01XA01
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
||
|
WHO-VATC |
QJ01XA01
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
||
|
WHO-ATC |
A07AA09
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
||
|
NDF-RT |
N0000007889
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
||
|
CFR |
21 CFR 862.3950
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
||
|
NDF-RT |
N0000175491
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB05076MIG
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
6Q205EH1VU
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
14969
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
Vancomycin
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
2807
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
D014640
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
DTXSID0042664
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
215-772-6
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
VANCOMYCIN
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
6Q205EH1VU
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
76842
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
CHEMBL262777
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
m11386
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | Merck Index | ||
|
100000085801
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
1404-90-6
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
680
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
11124
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | RxNorm | ||
|
3262
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
C925
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
DB00512
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY | |||
|
28001
Created by
admin on Sat Dec 16 17:07:19 UTC 2023 , Edited by admin on Sat Dec 16 17:07:19 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET->LIGAND | |||
|
TARGET ORGANISM->INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MIC | BIOLOGICAL |
|
SUSCEPTIBILITY: INTERMEDIATE |
|
||
MIC | BIOLOGICAL |
|
PATHOGEN: STREPTOCOCCI OTHER THAN S. PNEUMONIAE |
|
||
MIC | BIOLOGICAL |
|
PATHOGEN: ENTEROCOCCI AND COAGULASE-NEGATIVE STAPHYLOCOCCI |
|
||
MIC | BIOLOGICAL |
|
PATHOGEN: S. AUREUS |
|||
MIC | BIOLOGICAL |
|
SUSCEPTIBILITY: SUSCEPTIBLE |
|
||
MIC | BIOLOGICAL |
|
SUSCEPTIBILITY: SUSCEPTIBLE |
|
||
Biological Half-life | PHARMACOKINETIC |
|
POPULATION: CHILDREN AND ADOLESCENTS > 3 YEARS |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
POPULATION: PEDIATRICS |
|
||
Biological Half-life | PHARMACOKINETIC |
|
POPULATION: NEWBORNS |
|
||
Biological Half-life | PHARMACOKINETIC |
|
POPULATION: INFANTS AND CHILDREN 3 MONTHS TO 4 YEARS |
|
||
Biological Half-life | PHARMACOKINETIC |
|
RENAL FUNCTION: NORMAL |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
POPULATION: ADULTS |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
POPULATION: NEONATES |
|
||
MIC | BIOLOGICAL |
|
PATHOGEN: ENTEROCOCCI AND COAGULASE-NEGATIVE STAPHYLOCOCCI |
|
||
Biological Half-life | PHARMACOKINETIC |
|
RENAL FUNCTION: END-STAGE RENAL DISEASE |
|
||